Veryan Medical Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Veryan Medical Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0174
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veryan Medical Ltd (Veryan), a subsidiary of Veryan Holdings Ltd, is a medical device company that designs and develops vascular biomimetic stents. It develops BioMimics 3D stent, a peripheral self-expanding nickel-titanium alloy (Nitinol) stent with unique three-dimensional helical centreline geometry. The stent’s 3D helical-shape results in the shortening of the stented part during knee flexion and minimizes the risk of compression that causes localised strain. Veryan’s self-expanding stent system helps improve luminal diameter in symptomatic restenotic lesions in native superficial femoral and proximal popliteal arteries. A technology spin out from Imperial College, London, Veryan has a research and development facility in Galway, Ireland. It has a presence in the UK and Germany. Veryan is headquartered in Horsham, West Sussex, the UK.

Veryan Medical Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veryan Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veryan Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veryan Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veryan Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Veryan Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veryan Medical Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Veryan Medical Raises USD10.6 Million in Equity Financing 10
Veryan Medical Raises USD27 Million in Series B Venture Financing 11
Partnerships 12
Biosensors International Enters into Distribution Agreement with Veryan Medical for BioMimics 3D Stent 12
Veryan Medical Ltd – Key Competitors 13
Veryan Medical Ltd – Key Employees 14
Veryan Medical Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
Sep 12, 2017: First Round Of Late-Breaking Endovascular Clinical Trial Results Announced At VIVA 17 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Veryan Medical Ltd, Medical Equipment, Key Facts, 2016 2
Veryan Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Veryan Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veryan Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veryan Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veryan Medical Ltd, Deals By Market, 2012 to YTD 2018 8
Veryan Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veryan Medical Raises USD10.6 Million in Equity Financing 10
Veryan Medical Raises USD27 Million in Series B Venture Financing 11
Biosensors International Enters into Distribution Agreement with Veryan Medical for BioMimics 3D Stent 12
Veryan Medical Ltd, Key Competitors 13
Veryan Medical Ltd, Key Employees 14
Veryan Medical Ltd, Other Locations 15
Veryan Medical Ltd, Subsidiaries 15

List of Figures
Veryan Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Veryan Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Veryan Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Veryan Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Veryan Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veryan Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Veryan Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veryan Medical Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Veryan Medical Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Detroit Medical Center:企業の戦略的SWOT分析
    Detroit Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Pentax Europe GmbH-医療機器分野:企業M&A・提携分析
    Summary Pentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corp is a medical device company that provides clinical endo-imaging solutions. The company offers products in the therapeutic areas of gastroenterology, endoscopic ultrasound, ENT and speech, pulmonology, and urology. Its products in …
  • Biotest Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Biotest Pharmaceuticals Corp (Biotest Pharmaceuticals), a subsidiary of Biotest AG, is a manufacturer and distributor of of pharmaceutical and biotherapeutic products. The company offers products such as bivigam, nabi hb, hepatitis c immune globulin and plasma for further manufacturing. It o …
  • Hydro One Ltd (H):電力:M&Aディール及び事業提携情報
    Summary Hydro One Ltd (Hydro One) is a utility holding company that conducts electricity transmission and distribution in Ontario through its subsidiaries. It also undertakes telecommunications business and certain corporate activities. The company serves residential, commercial and industrial custo …
  • Celsense Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celsense Inc (Celsense) is a biotechnology company that develops magnetic resonance imaging detection products. The company’s products include v-sense, cell sense and voxel tracker. Its v-sense product is used to detect a range of lesions and diseases where inflammation is a hallmark such as …
  • Bumi Armada Bhd (ARMADA):企業の財務・戦略的SWOT分析
    Bumi Armada Bhd (ARMADA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Celulosa Arauco y Constitucion SA:企業の戦略的SWOT分析
    Celulosa Arauco y Constitucion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Amedica Corp (AMDA):製品パイプライン分析
    Summary Amedica Corp (Amedica) is a biomaterial company. It develops, manufactures and markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems and others. Amedica also offers n …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products . The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It comb …
  • Fuji Electric Co Ltd (6504):企業の財務・戦略的SWOT分析
    Fuji Electric Co Ltd (6504) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析
    Summary C. R. Bard Inc (Bard) is a medical device company, which offers medical, surgical, diagnostic and patient care devices related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. Its major products include devices for the treatment of peripheral …
  • Eesti Energia AS:電力:M&Aディール及び事業提携情報
    Summary Eesti Energia AS (Eesti Energia) is an international energy company. It offers energy solutions ranging from electricity, heat and fuel production to sales, customer service and ancillary energy services among others. Eesti Energia sells electricity to the Baltic retail customers and the who …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Korea South-East Power Co Ltd:企業の戦略的SWOT分析
    Korea South-East Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Leap Therapeutics Inc (LPTX)-医療機器分野:企業M&A・提携分析
    Summary Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that acquires, develops novel therapeutics for cancer research. The company’s pipeline encompasses DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, and in clinical tria …
  • Goals Soccer Centres plc:企業の戦略的SWOT分析
    Goals Soccer Centres plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Samyang Comtech Co., Ltd.:企業の戦略・SWOT・財務情報
    Samyang Comtech Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samyang Comtech Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析
    Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cytox Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict …
  • Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY):企業の財務・戦略的SWOT分析
    Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆